Aurinia Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need.
2024/3/19 6:56:43
(AUPH:NASDAQ - AUP:TSX)